Pharmaceutical company campaign against omega-3 supplements won’t proceed in trade court

Amarin alleged that concentrated omega-3 supplements represented unfair competition to its fish oil prescription drug, but U.S. International Trade Commission opted not to take case after the FDA claimed jurisdiction.